Two Sigma Investments’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21M | Sell |
576,901
-56,251
| -9% | -$2.05M | 0.04% | 521 |
|
2025
Q1 | $22.9M | Buy |
633,152
+18,204
| +3% | +$659K | 0.05% | 426 |
|
2024
Q4 | $25.9M | Sell |
614,948
-140,735
| -19% | -$5.92M | 0.06% | 382 |
|
2024
Q3 | $42M | Buy |
755,683
+187,374
| +33% | +$10.4M | 0.09% | 260 |
|
2024
Q2 | $23.4M | Buy |
568,309
+152,995
| +37% | +$6.29M | 0.05% | 390 |
|
2024
Q1 | $19.4M | Buy |
415,314
+288,704
| +228% | +$13.5M | 0.05% | 422 |
|
2023
Q4 | $6.05M | Buy |
126,610
+87,410
| +223% | +$4.18M | 0.01% | 832 |
|
2023
Q3 | $1.4M | Sell |
39,200
-364,574
| -90% | -$13M | ﹤0.01% | 1660 |
|
2023
Q2 | $18.6M | Sell |
403,774
-84,582
| -17% | -$3.9M | 0.05% | 397 |
|
2023
Q1 | $19.6M | Buy |
488,356
+46,420
| +11% | +$1.86M | 0.06% | 367 |
|
2022
Q4 | $20.5M | Buy |
441,936
+186,547
| +73% | +$8.64M | 0.06% | 337 |
|
2022
Q3 | $10.6M | Buy |
255,389
+198,889
| +352% | +$8.24M | 0.04% | 464 |
|
2022
Q2 | $3.37M | Buy |
56,500
+17,600
| +45% | +$1.05M | 0.01% | 893 |
|
2022
Q1 | $2.83M | Buy |
+38,900
| New | +$2.83M | 0.01% | 1157 |
|
2021
Q4 | – | Sell |
-25,900
| Closed | -$2.34M | – | 3015 |
|
2021
Q3 | $2.34M | Sell |
25,900
-264,364
| -91% | -$23.8M | 0.01% | 1280 |
|
2021
Q2 | $27.7M | Buy |
290,264
+145,944
| +101% | +$13.9M | 0.06% | 333 |
|
2021
Q1 | $16.4M | Buy |
144,320
+84,008
| +139% | +$9.56M | 0.04% | 428 |
|
2020
Q4 | $8.35M | Buy |
60,312
+54,595
| +955% | +$7.56M | 0.02% | 558 |
|
2020
Q3 | $470K | Sell |
5,717
-33,837
| -86% | -$2.78M | ﹤0.01% | 1444 |
|
2020
Q2 | $3.09M | Buy |
+39,554
| New | +$3.09M | 0.02% | 726 |
|
2019
Q4 | – | Sell |
-7,759
| Closed | -$332K | – | 2452 |
|
2019
Q3 | $332K | Buy |
+7,759
| New | +$332K | ﹤0.01% | 1608 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 2376 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 2389 |
|
2015
Q4 | – | Sell |
-150,113
| Closed | -$14.5M | – | 2235 |
|
2015
Q3 | $14.5M | Buy |
150,113
+4,772
| +3% | +$460K | 0.07% | 281 |
|
2015
Q2 | $14.9M | Buy |
145,341
+132,520
| +1,034% | +$13.6M | 0.07% | 327 |
|
2015
Q1 | $796K | Buy |
+12,821
| New | +$796K | ﹤0.01% | 1493 |
|